Prostate Cancer - PSA

Prostate cancer is the most frequent malignant neoplasm in men and the second most common cancer death among American men. Prostate-specific antigen (PSA) is used for prostate cancer screening starting at age 50, except in cases of increased risk.

Tabs Content

Last Update: June 2018